These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

233 related articles for article (PubMed ID: 7543145)

  • 1. Samarium-153-EDTMP for palliation of ankylosing spondylitis, Paget's disease and rheumatoid arthritis.
    Alberts AS; Brighton SW; Kempff P; Louw WK; Beek AV; Kritzinger V; Westerink HP; van Rensburg AJ
    J Nucl Med; 1995 Aug; 36(8):1417-20. PubMed ID: 7543145
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Samarium-153 EDTMP therapy of disseminated skeletal metastasis.
    Turner JH; Martindale AA; Sorby P; Hetherington EL; Fleay RF; Hoffman RF; Claringbold PG
    Eur J Nucl Med; 1989; 15(12):784-95. PubMed ID: 2483138
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Samarium-153-EDTMP in bone metastases.
    Ahonen A; Joensuu H; Hiltunen J; Hannelin M; Heikkilä J; Jakobsson M; Jurvelin J; Kairemo K; Kumpulainen E; Kulmala J
    J Nucl Biol Med (1991); 1994 Dec; 38(4 Suppl 1):123-7. PubMed ID: 7543288
    [TBL] [Abstract][Full Text] [Related]  

  • 4. High-dose samarium-153 ethylene diamine tetramethylene phosphonate: low toxicity of skeletal irradiation in patients with osteosarcoma and bone metastases.
    Anderson PM; Wiseman GA; Dispenzieri A; Arndt CA; Hartmann LC; Smithson WA; Mullan BP; Bruland OS
    J Clin Oncol; 2002 Jan; 20(1):189-96. PubMed ID: 11773169
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Samarium-153-EDTMP biodistribution and dosimetry estimation.
    Eary JF; Collins C; Stabin M; Vernon C; Petersdorf S; Baker M; Hartnett S; Ferency S; Addison SJ; Appelbaum F
    J Nucl Med; 1993 Jul; 34(7):1031-6. PubMed ID: 7686217
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [153Sm-EDTMP for moderate and severe bone cancer pain].
    Deng H; Luo S; Tan T; Mo T; Liang Z; Pu M; Jiao J; Zhong S; Wang Q; Hu Y
    Hua Xi Yi Ke Da Xue Xue Bao; 1995 Dec; 26(4):391-4. PubMed ID: 8732058
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A phase I study of samarium-153 ethylenediaminetetramethylene phosphonate therapy for disseminated skeletal metastases.
    Turner JH; Claringbold PG; Hetherington EL; Sorby P; Martindale AA
    J Clin Oncol; 1989 Dec; 7(12):1926-31. PubMed ID: 2585026
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Samarium for osteoblastic bone metastases and osteosarcoma.
    Anderson P
    Expert Opin Pharmacother; 2006 Aug; 7(11):1475-86. PubMed ID: 16859431
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A dose-controlled study of 153Sm-ethylenediaminetetramethylenephosphonate (EDTMP) in the treatment of patients with painful bone metastases.
    Resche I; Chatal JF; Pecking A; Ell P; Duchesne G; Rubens R; Fogelman I; Houston S; Fauser A; Fischer M; Wilkins D
    Eur J Cancer; 1997 Sep; 33(10):1583-91. PubMed ID: 9389919
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Multicentre trial on the efficacy and toxicity of single-dose samarium-153-ethylene diamine tetramethylene phosphonate as a palliative treatment for painful skeletal metastases in China.
    Tian JH; Zhang JM; Hou QT; Oyang QH; Wang JM; Luan ZS; Chuan L; He YJ
    Eur J Nucl Med; 1999 Jan; 26(1):2-7. PubMed ID: 9933654
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Human pharmacokinetics of samarium-153 EDTMP in metastatic cancer.
    Singh A; Holmes RA; Farhangi M; Volkert WA; Williams A; Stringham LM; Ketring AR
    J Nucl Med; 1989 Nov; 30(11):1814-8. PubMed ID: 2478681
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Systemic metabolic radiotherapy with samarium-153 EDTMP for the treatment of painful bone metastasis.
    Serafini AN
    Q J Nucl Med; 2001 Mar; 45(1):91-9. PubMed ID: 11456381
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dosimetry and toxicity of samarium-153-EDTMP administered for bone pain due to skeletal metastases.
    Bayouth JE; Macey DJ; Kasi LP; Fossella FV
    J Nucl Med; 1994 Jan; 35(1):63-9. PubMed ID: 7505819
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Samarium lexidronam (153Sm-EDTMP): skeletal radiation for osteoblastic bone metastases and osteosarcoma.
    Anderson P; Nuñez R
    Expert Rev Anticancer Ther; 2007 Nov; 7(11):1517-27. PubMed ID: 18020921
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Inhibitory effect of samarium-153-labeled ethylenediaminetetramethylene phosphonate (EDTMP) on bone invasion and osteolysis in Walker 256 carcinoma bearing rats].
    Shi B; Fu Z; Lei XH
    Zhonghua Zhong Liu Za Zhi; 1997 Nov; 19(6):423-6. PubMed ID: 10920873
    [TBL] [Abstract][Full Text] [Related]  

  • 16. ESR dosimetry of 89Sr and 153Sm in bone.
    Kinoshita A; Braga FJ; Graeff CF; Baffa O
    Appl Radiat Isot; 2001 Feb; 54(2):269-74. PubMed ID: 11200888
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Samarium-153-EDTMP dosimetry.
    Heggie JC
    J Nucl Med; 1994 Jan; 35(1):191-2. PubMed ID: 8271053
    [No Abstract]   [Full Text] [Related]  

  • 18. Samarium-153 lexidronam for painful bone metastases.
    Med Lett Drugs Ther; 1997 Aug; 39(1008):83-4. PubMed ID: 9286284
    [No Abstract]   [Full Text] [Related]  

  • 19. Evaluation of a freeze-dried kit for EDTMP-based bone-seeking radiopharmaceuticals.
    Garnuszek P; Pawlak D; Licińska I; Kamińska A
    Appl Radiat Isot; 2003 Apr; 58(4):481-8. PubMed ID: 12672628
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Samarium-153-labelled EDTMP for bone metastases from cancer of the prostate.
    Sandeman TF; Budd RS; Martin JJ
    Clin Oncol (R Coll Radiol); 1992 May; 4(3):160-4. PubMed ID: 1375094
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.